The Global Topical Analgesics / Pain Relief Market is segmented by Drug Type (Non-Opioids, Opioids), Formulation (Cream, Patch, Spray, Gel, Other Formulations), Type (Over the Counter (OTC) Analgesic and Prescription Analgesic), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Snapshot img

Over-The-Counter (OTC) Analgesics Market Size 2024-2028

The over-the-counter (otc) analgesics market size is forecast to increase by USD 7.2 billion at a CAGR of 4.98% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing aging population worldwide and the rising number of product launches. The global population aged 60 and above is projected to more than double by 2050, creating a substantial demand for pain relief solutions. This demographic shift, coupled with the growing awareness and acceptance of self-care, is fueling the market's expansion. However, the market's growth is not without challenges. The number of product recalls due to safety concerns and regulatory issues has been on the rise, posing significant risks for market players. These incidents can lead to reputational damage, regulatory penalties, and lost sales. Companies must prioritize product safety and quality to mitigate these risks and maintain consumer trust. To capitalize on the market opportunities and navigate challenges effectively, companies should focus on innovation, regulatory compliance, and strategic partnerships. Investing in research and development to launch new products that cater to the evolving consumer preferences and regulatory requirements can help companies stay competitive. Building strong relationships with regulatory bodies and industry associations can also help companies navigate the complex regulatory landscape and mitigate risks associated with product recalls. By addressing these challenges and leveraging market trends, companies can seize opportunities in the growing OTC Analgesics Market.

What will be the Size of the Over-The-Counter (OTC) Analgesics Market during the forecast period?

Request Free SampleThe market encompasses a wide range of pain medicines, including nonsteroidal anti-inflammatory drugs (NSAIDs) and topical analgesics, designed to alleviate various types of pain such as joint pains and chronic pain. These products are readily available in multiple distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. The geriatric population and the aging population are significant consumer groups, given the prevalence of joint pains and chronic conditions among older adults. Pregnant women also utilize OTC pain medicines for certain indications, following consultation with healthcare professionals. Internal OTC analgesics and external OTC analgesics cater to different pain management needs. Off-label uses of these drugs continue to expand, reflecting the evolving role of OTC analgesics in pain management programs. The market's size and growth are influenced by factors such as increasing prevalence of chronic pain conditions, expanding distribution channels, and consumer preferences for self-care and convenience.

How is this Over-The-Counter (OTC) Analgesics Industry segmented?

The over-the-counter (otc) analgesics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. TypeInternalExternalDistribution ChannelOfflineOnlineGeographyNorth AmericaUSEuropeGermanyUKAsiaRest of World (ROW)

By Type Insights

The internal segment is estimated to witness significant growth during the forecast period.The market encompasses internal and external analgesics used for pain relief. Internal analgesics, meant for ingestion, dominate the market, accounting for the largest share in 2023. Major drugs in this segment include acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen. Factors driving market growth include increasing pain-related conditions, self-medication trend, and healthcare expenditure. Key players invest in advertising campaigns to promote their brands, including Aleve, Advil, Crocin, MOTRIN, Aspirin, Excedrin, and TYLENOL. Chronic pain disorders, particularly among the geriatric population, pregnant women, and middle-lower class families, fuel demand for OTC analgesics. Distribution through hospital pharmacies, retail pharmacies, online pharmacies, and distribution stores further expands accessibility. Safety concerns and price sensitivity influence consumer preferences. Internal analgesics offer relief for chronic back pain, arthritis, and musculoskeletal diseases, among others. Despite stringent regulations, the market continues to grow, driven by increasing health awareness and the availability of non-opioid analgesics.

Get a glance at the market report of share of various segments Request Free Sample

The Internal segment was valued at USD 17.63 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 42% to the growth of the global m

In that 2019, the Icy Hot brand generated 18.6 percent of external analgesic rub sales in the United States. Boiron Arnicare generated 2.7 percent of sales.

In 2019, Icy Hot was the country's top selling external analgesic rub brand with sales that amounted to about 155.9 million U.S. dollars. Ranking second, Salonpas generated sales of up to 121.3 million U.S. dollars.

As the world continues to face chronic pain disorder burden, efficient and relieving topical pain relief becomes paramount for managing this condition. Given this, global demand for topical pain relief is anticipated to surge at a 5.6% CAGR through 2034.

Country-wise Insights

Category-wise Insights

By Application:The USA topical pain relief market is also segmented by application into joint pain, muscle pain, arthritis, and sports injuries. Joint pain remains the dominant sub-segment, accounting for the largest market share. This is due to the high prevalence of osteoarthritis and rheumatoid arthritis in the aging population, along with an increasing awareness of topical treatments as a safer alternative to oral medications. The growing demand for non-invasive solutions to manage chronic joint pain has led to the development of highly effective topical products. By Product Type:The USA topical pain relief market is segmented by product type into creams, gels, sprays, and patches. Creams currently hold the dominant market share due to their widespread usage for conditions such as arthritis, muscle pain, and general joint discomfort. Their ease of application, fast absorption, and long-lasting effects make them a popular choice among consumers. Additionally, major brands such as Biofreeze and Salonpas have contributed to the cream segments growth with strong brand loyalty and extensive product portfolios. USA Topical Pain Relief Market Segmentation The FDA enforces strict labeling requirements for topical pain relief products to ensure transparency and consumer safety. In 2024, updated guidelines mandate manufacturers to include detailed ingredient lists, usage instructions, and potential side effects on labels. These measures help consumers make informed decisions and reduce misuse risks. Non-compliance can lead to fines, recalls, or removal from the market, making adherence crucial for manufacturers' success.

The United States topical pain relief market size reached around USD 3.30 Billion in 2024. The market is projected to grow at a CAGR of 8.60% between 2025 and 2034 to reach nearly USD 7.53 Billion by 2034.

In 2019, Icy Hot, the leading U.S. external analgesic rub brand, showed a sales growth of 9.7 percent compared to the previous year. In comparison, Bengay's sales decreased by 18.7 percent.

In 2019, Icy Hot was the leading U.S. external analgesic rub brand with sales of 155.9 million U.S. dollars. Boiron Arnicare generated sales of up to 22.5 million U.S. dollars.

Global Topical Analgesic Market size valued at US$ 5.82 Billion in 2023, set to reach US$ 11.59 Billion by 2032 at a CAGR of about 7.1% from 2024-2032.

The Pain Management Industry is Segmented by Mode of Pain Management (Drugs (Opioids and Non-narcotic Analgesics (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-depressants, and Other Non-narcotic Analgesics)), Devices (Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation (TENS) Devices and Brain and Spinal Cord Stimulation (SCS) Devices)), and Analgesics Infusion Pumps (Intrathecal Infusion Pumps and External Infusion Pumps)), by Application (Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain, and Other Applications), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

The United States over the counter (OTC) drugs market size reached USD 41.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 65.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.4% during 2025-2033. The increasing consumer health awareness, cost-effectiveness of OTC drugs, regulatory support for prescription to OTC switches, rising aging population, and technological advancements in drug development and e-commerce are some of the factors propelling the market growth.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product type, route of administration, dosage form, and distribution channel.

[195 Pages Report] Sales in the global Non-Opioid Pain Patches Market are slated to top US$ 3.3 Bn in 2022. Expanding at a healthy 4.1% CAGR, the market size is projected to total US$ 4.4 Bn by 2029.

How The Market Progressed Till June 2022?

Scope of Report

Snapshot img

Veterinary Pain Management Market Size 2024-2028

The veterinary pain management market size is forecast to increase by USD 800.12 million at a CAGR of 6.99% between 2023 and 2028.

The market is experiencing significant growth due to several key factors. The rising trend of pet ownership is driving the demand for effective pain management solutions for animals. As pet owners prioritize their pets' health and well-being, they are increasingly seeking veterinary care for pain management. Alternative pain relief methods such as acupuncture, massage, and herbal remedies are gaining popularity in veterinary practice.
Risisng adoption of multimodal pain management strategies, which integrate various treatment approaches for comprehensive pain relief, is gaining traction within the veterinary field. However, a lack of awareness and education about veterinary pain management continues to hinder market growth. Raising awareness among veterinarians and pet owners about the significance of effective pain management and available treatment options is crucial for enhancing animal health and welfare.

What will be the Veterinary Pain Management Market Size During the Forecast Period?

Request Free Sample

The market is witnessing significant growth due to the increasing awareness of animal welfare and the advancement of non-invasive pain relief techniques. The market encompasses various pain management solutions, including topical and oral medications, non-steroidal anti-inflammatory drugs (NSAIDs), surgical laser therapy, transcutaneous electrical nerve stimulation (TENS), and therapeutic laser therapy. Post-surgical recovery is a critical phase in veterinary medicine where pain management plays a crucial role. Traditional methods of pain relief include NSAIDs and opioids, but the demand for alternative, non-invasive therapies such as TENS and therapeutic laser therapy is increasing.



Animal wound healing is another area where pain management is essential. Inflammation in animals can lead to chronic pain and delayed healing. TPEMF (Transcranial Pulsed Electromagnetic Field) therapy is an emerging technology that can aid in wound healing and pain relief by promoting tissue regeneration and reducing inflammation. Cancer treatment in animals often involves managing pain as a primary concern. Cancer pain can be acute or chronic, and traditional pain relief methods may not always be effective.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Drugs
  Devices


Distribution Channel

  Veterinary hospitals
  Pet care clinics
  Pharmacy stores


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    Japan


  Rest of World (ROW)

By Product Insights

The drugs segment is estimated to witness significant growth during the forecast period.

The market's drugs segment is experiencing notable expansion due to heightened concern for animal welfare and the rising incidence of diseases causing discomfort in animals. This segment encompasses pharmaceuticals like nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and analgesics, which offer effective pain relief for companion animals and livestock. Notable examples include carprofen, a widely-used NSAID for dogs, and meloxicam, which boasts both anti-inflammatory and analgesic properties. The escalating demand for species-specific medications, coupled with continuous research and innovation in veterinary pharmacology, is poised to fuel the growth of the drugs segment and, consequently, The market throughout the forecast period.

In addition to pharmaceutical solutions, non-pharmaceutical pain management techniques are gaining traction in veterinary practices. These methods include physical and physiological therapies such as laser therapy, temperature regulation, and massage. Laser therapy, for instance, is increasingly being utilized to alleviate pain and inflammation in animals by stimulating tissue repair and promoting the production of endorphins. By addressing the diverse needs of animals and complementing pharmaceutical treatments, non-pharmaceutical pain management methods are expected to contribute significantly to the growth of the market. Equipment used for non-pharmaceutical pain management, such as laser therapy devices, temperature regulators, and massage tables, are also witnessing increased adoption in veterinary practices.

Get a glance at the market report of share of various segments Request Free Sample

The Drugs segment was valued at USD 1.05 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to co

The revenue in the 'Analgesics' segment of the otc pharmaceuticals market in the Philippines was forecast to continuously increase between 2024 and 2029 by in total 121.6 million U.S. dollars (+63.47 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 313.15 million U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Analgesics' segment of the otc pharmaceuticals market was continuously increasing over the past years.Find other key market indicators concerning the average revenue per user (ARPU) and revenue growth. The Statista Market Insights cover a broad range of additional markets.

According to Cognitive Market Research, the global Voltaren market size will be USD 5521.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 2208.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1656.45 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1269.95 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 276.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 110.43 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
The Gel category is the fastest growing segment of the Voltaren industry

Market Dynamics of Voltaren Market

Key Drivers for Voltaren Market

Increasing prevalence of musculoskeletal disorders to Boost Market Growth

The increasing prevalence of musculoskeletal disorders, such as arthritis, osteoarthritis, and chronic back pain, is a key driver of the Voltaren market. As the global population ages, the incidence of these conditions rises, leading to higher demand for effective pain relief solutions. Voltaren, a topical analgesic, provides targeted pain relief for these conditions, making it a preferred choice among individuals seeking non-invasive treatments. The convenience of topical application, combined with fewer side effects compared to oral medications, further boosts its appeal. Additionally, rising awareness of the importance of managing chronic pain and improving quality of life has led to a growing consumer preference for products like Voltaren. As musculoskeletal disorders continue to impact more people, Voltaren's market presence expands, addressing the increasing demand for effective pain management. For instance in May 2023, Scilex Holding Company, a Sorrento Company, initiated Phase 2, a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of SP-103 (lidocaine topical system) in subjects with acute low back pain.

Increasing prevalence of musculoskeletal disorders to Drive Market Growth

The growing preference for topical treatments is significantly driving the Voltaren market due to their targeted effectiveness and lower risk of side effects compared to oral medications. Many consumers seek alternatives to oral pain relievers to avoid potential gastrointestinal issues, liver strain, or addiction risks associated with systemic treatments. Voltaren, as a non-prescription topical analgesic, delivers pain relief directly to the affected area, providing faster and localized results. This direct application also reduces the chances of systemic side effects, making it particularly appealing to individuals with chronic conditions like arthritis or muscle pain. Additionally, topical treatments like Voltaren are perceived as more convenient and easier to use, with no need for prescriptions in many markets. As consumer demand for safer, more efficient solutions rises, Voltaren’s market growth is strengthened.

Restraint Factor for the Voltaren Market

Side effects and allergies will Limit Market Growth

Side effects and allergies are significant restraints on the Voltaren market, as some users experience skin irritation, rashes, or allergic reactions to the active ingredients, particularly diclofenac. These adverse reactions may limit its appeal to individuals with sensitive skin or those prone to allergic responses. While Voltaren is a topical analgesic, it is not completely free from side effects, which can discourage consumers from using it regularly. The risk of irritation or other skin-related side effects may also lead to concerns among healthcare professionals when recommending Voltaren to patients with pre-existing skin conditions. As consumers increasingly seek products with fewer or no side effects, concerns about potential allergic reactions can hinder Voltaren'...

Global Acute Otitis Media Treatment Market market valued at US$ 2.06 Billion in 2023, projected to grow 4.96% CAGR to US$ 3.19 Billion by 2032.